| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-03-24 | Lazar David E. Director | Sale | -108,936,000 | -98.14%2,064,000 | N/A | N/A | View SEC filing | |
| 2023-08-16 | Anderson Glen R. 10% Owner | Purchase | +103,352 | +9.51%1,190,400 | $2.09 | $216,388 | View SEC filing | |
| 2022-12-19 | Litchev Boyan Vesselinov Chief Medical Officer | Purchase | +1,150 | +100.00%1,150 | $2.19 | $2,520 | View SEC filing | |
| 2022-11-22 | Meckler Jeffrey A CEO and Director | Purchase | +10,000 | +15.30%75,374 | $1.89 | $18,945 | View SEC filing | |
| 2022-09-12 | Meckler Jeffrey A CEO and Director | Purchase | +10,308 | +18.72%65,374 | $2.80 | $28,862 | View SEC filing | |
| 2022-09-09 | Linscott Walt Addison Chief Business Officer | Purchase | +150 | +100.00%150 | $2.62 | $393 | View SEC filing | |
| 2022-09-08 | Meckler Jeffrey A CEO and Director | Purchase | +9,692 | +21.36%55,066 | $2.56 | $24,771 | View SEC filing | |
| 2022-06-07 | Meckler Jeffrey A CEO and Director | Purchase | +19,727 | +76.92%45,374 | $2.63 | $51,882 | View SEC filing | |
| 2022-02-02 | Newman Michael James CSO and Director | Sale | -20,000 | -1.44%1,368,356 | $5.00 | $100,043 | View SEC filing | |
| 2021-11-19 | Meckler Jeffrey A CEO and Director | Purchase | +11,187 | +77.37%25,647 | $5.82 | $65,108 | View SEC filing | |
| 2021-09-16 | Meckler Jeffrey A CEO and Director | Purchase | +12,000 | +487.80%14,460 | $7.00 | $84,000 | View SEC filing |
1-11 of 11
